Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
PTEN Phosphohydrolase | 14 | 2020 | 1119 | 0.810 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2015 | 1339 | 0.410 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2018 | 2952 | 0.360 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2016 | 2066 | 0.340 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3610 | 0.320 |
Why?
|
Prostatic Neoplasms | 11 | 2020 | 11221 | 0.310 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2021 | 249 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5336 | 0.300 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2812 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2024 | 2460 | 0.290 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2024 | 3617 | 0.280 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18362 | 0.280 |
Why?
|
Mice | 41 | 2024 | 82017 | 0.260 |
Why?
|
Anilides | 2 | 2020 | 414 | 0.260 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 88 | 0.250 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13697 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5422 | 0.250 |
Why?
|
Cytochromes c | 1 | 2005 | 173 | 0.250 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2018 | 103 | 0.240 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 17135 | 0.230 |
Why?
|
Pericytes | 2 | 2018 | 299 | 0.220 |
Why?
|
RNA, Ribosomal | 2 | 2019 | 227 | 0.220 |
Why?
|
Indoles | 3 | 2019 | 1825 | 0.210 |
Why?
|
Animals | 47 | 2024 | 169337 | 0.210 |
Why?
|
Pantothenic Acid | 1 | 2022 | 17 | 0.210 |
Why?
|
Nuclear Proteins | 6 | 2019 | 5800 | 0.200 |
Why?
|
Coenzyme A | 1 | 2022 | 39 | 0.200 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4921 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1409 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8634 | 0.190 |
Why?
|
Computational Biology | 1 | 2013 | 3543 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2022 | 126 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8051 | 0.180 |
Why?
|
Caspases | 1 | 2004 | 881 | 0.180 |
Why?
|
Nipples | 1 | 2023 | 230 | 0.180 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1901 | 0.180 |
Why?
|
Androgen Receptor Antagonists | 1 | 2021 | 125 | 0.170 |
Why?
|
Sesquiterpenes | 1 | 2021 | 177 | 0.170 |
Why?
|
Lipogenesis | 2 | 2020 | 216 | 0.170 |
Why?
|
Glucose Transporter Type 3 | 1 | 2019 | 16 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2021 | 2884 | 0.160 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13576 | 0.160 |
Why?
|
Trans-Activators | 1 | 2009 | 2856 | 0.160 |
Why?
|
Dyskeratosis Congenita | 1 | 2019 | 70 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 768 | 0.160 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 506 | 0.160 |
Why?
|
Mutation | 10 | 2021 | 30228 | 0.160 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2360 | 0.150 |
Why?
|
Cytoplasm | 3 | 2013 | 1502 | 0.150 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2018 | 25 | 0.150 |
Why?
|
Databases, Factual | 1 | 2013 | 8075 | 0.150 |
Why?
|
Caveolin 1 | 1 | 2019 | 255 | 0.150 |
Why?
|
Organoids | 2 | 2021 | 746 | 0.150 |
Why?
|
Protein Phosphatase 1 | 1 | 2018 | 135 | 0.140 |
Why?
|
Anticarcinogenic Agents | 1 | 2019 | 251 | 0.140 |
Why?
|
Lipoylation | 1 | 2018 | 87 | 0.140 |
Why?
|
Cell Proliferation | 10 | 2024 | 10478 | 0.140 |
Why?
|
Pyridines | 2 | 2020 | 2889 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 393 | 0.140 |
Why?
|
Growth and Development | 1 | 2016 | 46 | 0.140 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2830 | 0.140 |
Why?
|
Signal Transduction | 14 | 2022 | 23631 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3620 | 0.140 |
Why?
|
Apoptosis | 5 | 2021 | 9516 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2058 | 0.130 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2016 | 42 | 0.130 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3458 | 0.130 |
Why?
|
DNA, Intergenic | 1 | 2016 | 108 | 0.130 |
Why?
|
Neoplasms | 5 | 2019 | 22385 | 0.130 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9562 | 0.130 |
Why?
|
Tretinoin | 1 | 2019 | 525 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1883 | 0.130 |
Why?
|
Proteomics | 2 | 2024 | 3906 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2021 | 864 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 325 | 0.130 |
Why?
|
Fertility | 1 | 2020 | 772 | 0.130 |
Why?
|
HMGB1 Protein | 1 | 2017 | 141 | 0.130 |
Why?
|
Genetic Pleiotropy | 1 | 2016 | 181 | 0.120 |
Why?
|
Cholesterol | 1 | 2024 | 2912 | 0.120 |
Why?
|
Pyrazines | 1 | 2021 | 1206 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2019 | 12805 | 0.120 |
Why?
|
Animal Husbandry | 1 | 2015 | 64 | 0.120 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 457 | 0.120 |
Why?
|
Hematopoiesis | 1 | 2004 | 2058 | 0.120 |
Why?
|
Transcription Factors | 5 | 2021 | 12166 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1083 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 637 | 0.120 |
Why?
|
Mice, SCID | 4 | 2021 | 2632 | 0.120 |
Why?
|
Elafin | 1 | 2014 | 30 | 0.120 |
Why?
|
Phthalazines | 1 | 2017 | 397 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2018 | 2846 | 0.120 |
Why?
|
Multiprotein Complexes | 3 | 2016 | 1110 | 0.110 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3407 | 0.110 |
Why?
|
Epigenomics | 1 | 2019 | 959 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 434 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 998 | 0.110 |
Why?
|
RNA | 2 | 2021 | 2726 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5708 | 0.110 |
Why?
|
Public Sector | 1 | 2015 | 266 | 0.110 |
Why?
|
Mice, Knockout | 8 | 2021 | 14481 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2015 | 370 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1628 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 413 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5443 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1766 | 0.110 |
Why?
|
Drug Repositioning | 1 | 2015 | 244 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 954 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2021 | 1755 | 0.100 |
Why?
|
NF-kappa B | 1 | 2021 | 2489 | 0.100 |
Why?
|
Therapies, Investigational | 1 | 2013 | 111 | 0.100 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 427 | 0.100 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 191 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 83 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3587 | 0.100 |
Why?
|
Private Sector | 1 | 2015 | 396 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1582 | 0.100 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2015 | 326 | 0.090 |
Why?
|
Humans | 50 | 2024 | 768393 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9614 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2021 | 3695 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1493 | 0.090 |
Why?
|
Histones | 1 | 2021 | 2592 | 0.090 |
Why?
|
Neutrophils | 2 | 2020 | 3785 | 0.090 |
Why?
|
Naphthyridines | 1 | 2012 | 181 | 0.090 |
Why?
|
Ribosomes | 1 | 2013 | 499 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 494 | 0.080 |
Why?
|
Myeloid Cells | 2 | 2018 | 832 | 0.080 |
Why?
|
Lysosomes | 3 | 2021 | 939 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3252 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21162 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2968 | 0.080 |
Why?
|
Oncogene Proteins | 2 | 2016 | 718 | 0.080 |
Why?
|
HEK293 Cells | 4 | 2019 | 4291 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1987 | 0.080 |
Why?
|
Interprofessional Relations | 1 | 2015 | 997 | 0.080 |
Why?
|
Drug Synergism | 2 | 2024 | 1762 | 0.080 |
Why?
|
Oncogenes | 2 | 2021 | 1235 | 0.080 |
Why?
|
Purines | 1 | 2012 | 615 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4738 | 0.070 |
Why?
|
Sarcoma | 1 | 2019 | 1807 | 0.070 |
Why?
|
Drug Approval | 1 | 2015 | 818 | 0.070 |
Why?
|
Medical Informatics | 1 | 2015 | 740 | 0.070 |
Why?
|
Regeneration | 1 | 2016 | 1525 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11918 | 0.070 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3939 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7211 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1067 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2552 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1169 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1249 | 0.070 |
Why?
|
Mass Spectrometry | 3 | 2022 | 2201 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 656 | 0.060 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2005 | 71 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4588 | 0.060 |
Why?
|
Androgens | 1 | 2013 | 1285 | 0.060 |
Why?
|
Open Reading Frames | 2 | 2020 | 812 | 0.060 |
Why?
|
Models, Biological | 6 | 2018 | 9493 | 0.060 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9510 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4450 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2940 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 461 | 0.060 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 195 | 0.060 |
Why?
|
Mice, Nude | 2 | 2021 | 3632 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4353 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 282 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1980 | 0.060 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2024 | 58 | 0.060 |
Why?
|
Androgen Antagonists | 1 | 2013 | 1421 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2060 | 0.060 |
Why?
|
Gene Knockout Techniques | 2 | 2019 | 808 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22355 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 710 | 0.060 |
Why?
|
Ubiquitination | 2 | 2019 | 1009 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3048 | 0.060 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 750 | 0.060 |
Why?
|
Proteome | 1 | 2013 | 1881 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1839 | 0.050 |
Why?
|
Male | 21 | 2021 | 364902 | 0.050 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.050 |
Why?
|
Mitosis | 2 | 2024 | 1190 | 0.050 |
Why?
|
Proteins | 3 | 2018 | 6006 | 0.050 |
Why?
|
Endosomes | 2 | 2016 | 525 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2004 | 738 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1682 | 0.050 |
Why?
|
Acetyl Coenzyme A | 1 | 2022 | 74 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6132 | 0.050 |
Why?
|
Protein Stability | 1 | 2024 | 580 | 0.050 |
Why?
|
Phosphorylation | 2 | 2024 | 8326 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Telomerase | 1 | 2006 | 752 | 0.050 |
Why?
|
Gene Amplification | 2 | 2018 | 1090 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 2003 | 0.050 |
Why?
|
Blotting, Western | 2 | 2009 | 5037 | 0.050 |
Why?
|
Gene Silencing | 3 | 2018 | 1503 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3541 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3434 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1753 | 0.050 |
Why?
|
Cell Cycle | 2 | 2024 | 2938 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 628 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7598 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 363 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1151 | 0.040 |
Why?
|
RNA, Small Nucleolar | 1 | 2019 | 27 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1153 | 0.040 |
Why?
|
HeLa Cells | 1 | 2005 | 3088 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2020 | 259 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 260 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 929 | 0.040 |
Why?
|
Leukemia | 1 | 2007 | 1526 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3779 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 322 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11854 | 0.040 |
Why?
|
COS Cells | 1 | 2020 | 1135 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 895 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2018 | 364 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5705 | 0.040 |
Why?
|
RNA Interference | 1 | 2005 | 2836 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 959 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2021 | 888 | 0.030 |
Why?
|
Methylation | 1 | 2019 | 1076 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1660 | 0.030 |
Why?
|
K562 Cells | 1 | 2018 | 644 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1703 | 0.030 |
Why?
|
RNA Splicing | 1 | 2021 | 903 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1135 | 0.030 |
Why?
|
Cytarabine | 1 | 2018 | 697 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 2002 | 0.030 |
Why?
|
Benzylamines | 1 | 2017 | 251 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1905 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 245 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4936 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 937 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1913 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3712 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2017 | 478 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4357 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 737 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1071 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1093 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 971 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1024 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2018 | 683 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1232 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1901 | 0.030 |
Why?
|
Heterozygote | 2 | 2011 | 2791 | 0.030 |
Why?
|
Protein Binding | 1 | 2005 | 9343 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2392 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 798 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 381 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4039 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1674 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 559 | 0.030 |
Why?
|
Valine | 1 | 2014 | 410 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2016 | 841 | 0.030 |
Why?
|
Gene Duplication | 1 | 2013 | 315 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3633 | 0.030 |
Why?
|
Nanostructures | 1 | 2017 | 553 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3663 | 0.020 |
Why?
|
Testosterone | 1 | 2023 | 2493 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1967 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1105 | 0.020 |
Why?
|
Phenylthiohydantoin | 1 | 2013 | 208 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13042 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5764 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 663 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3587 | 0.020 |
Why?
|
Orchiectomy | 1 | 2013 | 466 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2911 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1716 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2017 | 1155 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6541 | 0.020 |
Why?
|
Cell Line | 1 | 2004 | 15597 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 391 | 0.020 |
Why?
|
Fatty Acids | 1 | 2018 | 1815 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6892 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1019 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2533 | 0.020 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2010 | 122 | 0.020 |
Why?
|
Female | 8 | 2024 | 397089 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1608 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 2011 | 328 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4142 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2009 | 438 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4526 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5215 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10117 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1193 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1671 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2906 | 0.020 |
Why?
|
Mammals | 1 | 2013 | 1136 | 0.020 |
Why?
|
Nitriles | 1 | 2013 | 984 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 19022 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 867 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4352 | 0.020 |
Why?
|
Adenovirus E1A Proteins | 1 | 2007 | 81 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1380 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65379 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2663 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2017 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1064 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1221 | 0.020 |
Why?
|
Homozygote | 1 | 2010 | 1779 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 3078 | 0.010 |
Why?
|
Zebrafish | 1 | 2016 | 3037 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4785 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1674 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6406 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1726 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2673 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1356 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5796 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2010 | 2094 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12422 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7599 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13423 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2394 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17626 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10089 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10267 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3442 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2458 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 30022 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 945 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4177 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5900 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5801 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1399 | 0.010 |
Why?
|
Middle Aged | 2 | 2023 | 223491 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9433 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11668 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59686 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2544 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11120 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 18048 | 0.000 |
Why?
|
Aged | 1 | 2020 | 171562 | 0.000 |
Why?
|
Adult | 1 | 2020 | 223640 | 0.000 |
Why?
|